Hepatic knockdown of PPARγ in mice leads to resistance to high-fat-diet-induced hepatic steatosis and the decrease of genes involved in lipogenesis (SREBP1 and SCD1) and FA transporters regulated by PPARγ (CD36) [47]. Here, PPARG is linked to fatty liver disease.